Clinical response correlates with 4‐week postinjection ustekinumab concentrations in patients with moderate‐to‐severe psoriasis

BACKGROUND: Cost‐effective use of biologicals is important. As drug concentrations have been linked to clinical outcomes, monitoring drug concentrations is a valuable tool to guide clinical decision‐making. A concentration–response relationship for ustekinumab at trough is uncertain owing to the con...

Descripción completa

Detalles Bibliográficos
Autores principales: Van den Berghe, N., De Keyser, E., Soenen, R., Meuleman, L., Lanssens, S., Gils, A., Lambert, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028119/
https://www.ncbi.nlm.nih.gov/pubmed/31004510
http://dx.doi.org/10.1111/bjd.18016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028119/
https://www.ncbi.nlm.nih.gov/pubmed/31004510
http://dx.doi.org/10.1111/bjd.18016

Ejemplares similares